Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2024-07-29 00:00:00 ET · period of report 2024-07-25 · accession 0000950170-24-087435 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-07-29 | 2024-07-25+ | RLAY | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $5.04 | +86.7K | 802.8K | +12% | +$437.0K |
| DMT | 2024-07-29 | 2024-07-25+ | RLAY | Patel Sanjiv | Pres, CEO, Dir | S - Sale+OE | $9.12 | -86.7K | 766.1K | -10% | -$790.9K |
| DMT | 2024-07-29 | 2024-07-25+ | RLAY | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $0.00 | -86.7K | 518.8K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-25 | M | A | 50,000 | $5.04 | 816,130 | D | — | — | (F2) Includes 762,360 shares underlying restricted stock units. |
| 2 | Common | Common Stock | 2024-07-25 | S | D | 50,000 | $9.16 | 766,130 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $9.00 to $9.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 762,360 shares underlying restricted stock units. |
| 3 | Common | Common Stock | 2024-07-26 | M | A | 36,706 | $5.04 | 802,836 | D | — | — | (F2) Includes 762,360 shares underlying restricted stock units. |
| 4 | Common | Common Stock | 2024-07-26 | S | D | 36,706 | $9.07 | 766,130 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $9.00 to $9.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 762,360 shares underlying restricted stock units. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-07-26 | M | D | 36,706 | $0.00 | 482,073 | D | $5.04 · — to 2029-04-22 | 36,706 Common Stock | (F6) The shares underlying this option vested in sixteen (16) equal quarterly installments after April 23, 2019. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-07-25 | M | D | 50,000 | $0.00 | 518,779 | D | $5.04 · — to 2029-04-22 | 50,000 Common Stock | (F6) The shares underlying this option vested in sixteen (16) equal quarterly installments after April 23, 2019. |